This Act amends Part 11 of the Health Authority Act to govern the interim period between the law’s assent and the date all its provisions come into force. It continues the entity created by Health Authority Transition Regulation No. 1 as the “interim health authority,” sets out interim appointment rules for the initial board and chair, and gives the Minister, the initial board and related actors specific powers and limits during the transition.
The amendments also permit wider sharing and use of personal and health information for transition purposes, clarify the Yukon Hospital Corporation’s collaborative obligations, confirm that ministerial directives are not regulations under the Regulations Act, and add a novel extinguishment clause that bars almost all causes of action and remedies arising from actions taken under Part 11—while expressly preserving applications for judicial review and constitutional remedies. These changes prioritize administrative control and an orderly implementation, but they raise practical and legal questions about oversight, third-party contracts, privacy and access to remedies.
At a Glance
What It Does
The bill defines an interim period and continues the transition body as the interim health authority, authorizes the Minister and initial governance actors to take transition-related actions (often subject to prior ministerial approval), and allows information sharing needed for implementation. It also adds a provision extinguishing most causes of action tied to Part 11 activities, except judicial review and constitutional claims.
Who It Affects
Directly affected are the interim health authority (and its initial board, chair and CEO), the Yukon Hospital Corporation, the Minister and Executive Council, Yukon First Nations’ health committees, and contractors or counterparties engaging in transition contracts. Privacy officers, litigants and courts will also be affected by changes to information-sharing and the civil remedies bar.
Why It Matters
The Act governs how the health authority transition will operate in practice—who can make binding decisions, how disputes and contracts are treated during the transition, and what legal recourse is available. For compliance officers and counsel, the Act changes approval pathways, record-sharing rules, and the litigation landscape during the interim phase.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The amendments establish an “interim period” that runs from assent to the day the Act is fully in force, and they explicitly continue the body created by the earlier transition regulation as the interim health authority. That continuity is more than a label: the interim authority can act on operations, financing and contracts during the interim period, but the bill conditions the binding effect of many of those actions on prior ministerial approval.
Actions taken without that approval will not bind the Government of Yukon.
The bill reorganizes who can do what during the interim. The Commissioner in Executive Council may appoint an initial board, chair and set terms (two, three or four years), and may revoke appointments at any time.
The initial board, chair and initial CEO can exercise the powers of the interim authority—again generally with the Minister’s prior approval—and must implement any ministerial directives. The Yukon Hospital Corporation gets express authority to enter into transition-related agreements and a statutory duty to collaborate on decisions that could materially affect procurement, construction, financing or executive staffing.Information flows are relaxed for the transition: government actors, the Yukon Hospital Corporation and interim authority officers may share, collect and use personal and personal health information when necessary for transition purposes.
The Act clarifies that ministerial directives issued under the new Part are not regulations under the Regulations Act, meaning they are not subject to the same procedural or tabling requirements as formal regulations.Finally, the Act introduces a broad extinguishment clause: it says no cause of action, damages, costs or equitable remedies arise from the enactment, amendment or execution of Part 11, from regulations under it, from directives issued under it, or from anything done or omitted under it. There are explicit carve-outs: applications for judicial review and claims for constitutional remedies remain available, the provision must be applied consistently with section 35 of the Constitution Act, 1982, costs cannot be awarded in proceedings that are barred, and the clause does not apply to proceedings brought by the Government of Yukon itself.
The Five Things You Need to Know
The interim period runs from the date of assent until every provision of the Act is in force, making the duration open-ended and linked to proclamation or other commencement mechanics.
The Commissioner in Executive Council may appoint initial board members and the initial chair for staggered two-, three- or four-year terms and may revoke those appointments at any time (Section 100).
The interim health authority can enter into contracts and take operational and financing actions only with the Minister’s prior approval; agreements made without that approval do not bind the Government of Yukon (Section 101.01(2)-(3)).
Ministerial directives under the new Part may set timelines, require approvals, demand reports, and govern suspension or continuation of transition activities, and the Act states such directives are not regulations under the Regulations Act (Section 102(2)-(3)).
Section 107.01 bars almost all causes of action, remedies and proceedings tied to Part 11 actions (including damages, equitable remedies and enforcement of out-of-territory orders), but preserves judicial review and constitutional claims and requires compatibility with section 35 of the Constitution Act, 1982.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Defines ‘interim period’ and ‘interim health authority’
The Act adds two targeted definitions: “interim period” (assent to full commencement) and “interim health authority” (the body continued from Health Authority Transition Regulation No. 1). That frames all downstream authorities so that the subsequent powers, duties and limits are expressly limited to this transitional window rather than being open-ended.
Commissioner may appoint initial board and chair with revocation power
This provision lets the Commissioner in Executive Council appoint the initial board, including a chair, on the Minister’s recommendation, and to set staggered terms of two, three or four years. Critically it also says the Commissioner may revoke appointments at any time, establishing executive flexibility but also potential instability in governance continuity during transition.
Continues the transition entity as the interim health authority
The regulation-created body is rolled forward into the statute as the interim health authority. The authority can act on operations, financing and contracts for purposes tied to transition, but only with prior ministerial approval for actions the Minister considers necessary or advisable; actions without approval do not bind the Crown. The section also confirms the interim authority must follow directives issued under the new Part.
Grants broad, discretionary transitional powers and directive authority to the Minister
During the interim period the Minister may exercise ministerial powers to plan an orderly transition, assess impacts of coming-into-force, and suspend or stop transition activities. The Minister can enter into agreements and issue directives that may be general or specific, set timelines, require reviews or approvals, prescribe forms and demand reports. The Act expressly treats these directives as not being regulations under the Regulations Act, which affects procedural review and transparency.
Clears the initial board and executives to act, subject to ministerial approval and directives
The initial board, chair and CEO may exercise interim health authority powers with the Minister’s prior approval and are required to carry out ministerial directives. Practically, many operational decisions are conditional: approval gates mean the Minister controls what ultimately binds the government and sets the implementation pace.
Requires Yukon Hospital Corporation to collaborate on materially impactful decisions
The Yukon Hospital Corporation may enter into transition agreements and must work collaboratively with government and interim authority officers on decisions that materially affect procurement, construction, financial arrangements or executive staffing. The clause recognizes the Corporation’s existing role but imposes a statutory coordination duty during transition.
Permits sharing, collection and use of personal and health information for transition
Government actors, the Yukon Hospital Corporation and interim authority personnel may share, collect and use personal information and personal health information where necessary for transition purposes. This relaxes usual constraints to enable operational planning, but it is limited to information necessary or advisable for defined transition goals and thus raises compliance obligations under privacy regimes.
Broad bar on civil and equitable claims tied to Part 11, with narrow exceptions
This section prevents causes of action and most remedies (damages, equitable relief, enforcement of foreign judgments, etc.) against the Government, officials, the initial board and interim authority officers for anything done or omitted under Part 11, including directives and regulations. The bar does not stop judicial review or constitutional claims, must be applied compatibly with s.35 of the Constitution Act, 1982, and does not apply to proceedings brought by the Government of Yukon itself; costs cannot be awarded in proceedings that are barred.
This bill is one of many.
Codify tracks hundreds of bills on this topic across all five countries.
Explore this topic in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Government of Yukon — gains centralized control and legal insulation during the transition, enabling the Minister and Executive Council to steer implementation and limit financial exposure from transitional decisions.
- Interim health authority leadership (initial board, chair, CEO) — receives statutory continuity and explicit authority to act during transition, plus a clear approval pathway for carrying out operations and contracts.
- Yukon Hospital Corporation and health system planners — get statutory cover to enter transition agreements and a mandated collaborative role on procurement, construction, finance and executive staffing decisions, which reduces inter-organizational friction.
- Yukon First Nations’ health committees — the Act explicitly allows agreements and collaboration with these committees during transition, creating clear legal space for engagement and negotiation during implementation.
Who Bears the Cost
- Private contractors and counterparties — contracts or commitments entered without prior ministerial approval may not bind the Government of Yukon, increasing counterparty risk and potentially depressing contractor willingness or raising pricing.
- Initial board members, the chair and executives — their authority depends on ministerial approvals and directives, reducing independent decision-making and exposing them to political oversight or sudden revocation of appointments.
- Litigants and third parties seeking remedies — the extinguishment clause removes many civil and equitable remedies for harms arising from Part 11 activities, narrowing litigation options and creating limits on recovery for affected parties.
- Privacy officers and compliance teams — expanded information sharing and collection for transition purposes raises operational compliance burdens under territorial privacy requirements and requires careful policies and recordkeeping to limit downstream risk.
Key Issues
The Core Tension
The bill seeks to enable an orderly, government-controlled transition by concentrating approval authority in the Minister and insulating officials from most civil liability—trading off faster, centrally directed implementation against reduced external oversight, increased counterparty risk, constrained legal remedies for harmed parties and potential privacy and Indigenous-rights tensions.
The Act prioritizes administrative flexibility and risk-limitation for government, but that creates several implementation frictions. First, the Minister’s broad authority to approve, suspend or direct transition activities hinges on subjective standards—“necessary or advisable”—which will place a premium on documented decision-making and could fuel disputes over whether approvals were properly sought or withheld.
Because actions taken without prior approval do not bind the Crown, third parties face practical uncertainty when negotiating transition contracts; that uncertainty may translate into higher contractor rates or demands for Crown guarantees.
Second, the information-sharing permissions are narrow in purpose but broad in practice: they allow personal and health information to flow among government, the Yukon Hospital Corporation and interim authority personnel where “necessary or advisable.” That increases the risk of privacy law tension and will require precise governance, retention rules and security safeguards. There is also a transparency trade-off: the Act deems directives not to be regulations, which reduces procedural oversight under the Regulations Act and may limit parliamentary or public scrutiny of important implementation decisions.
Third, the extinguishment clause is legally aggressive. By removing virtually all causes of action and remedies (including equitable remedies and enforcement of out-of-territory orders), the provision reduces litigation risk for the Crown and transition actors but also limits redress for businesses, Indigenous governments and individuals affected by transition decisions.
Although judicial review and constitutional claims remain available, those remedies are narrower than full civil redress, and the clause’s compatibility statement with section 35 of the Constitution Act, 1982 leaves open how Indigenous rights claims will be reconciled in practice. Operationally, the provision will force counsel to rethink dispute-management strategies and may push parties toward negotiated settlements or administrative review processes rather than courts.
There's more to this law than the bill.
Codify Laws traces every connection across the legislative lifecycle.